Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Asfar

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 28, 2019
Early Use of Norepinephrine for Sepsis: Promising Results That Require ConfirmationNathan El Bèze, Antoine Kimmoun, Pierre Asfar
Intensive Care Medicine|February 17, 2026
Vasopressor use in septic shock: separating evidence, practice, and future directionsNicolas Fage, Michelle S Chew, Pierre Asfar
Critical Care (London, England)|November 12, 2010
Bench-to-bedside review: circulating microparticles--a new player in sepsis?Ferhat Meziani, Xavier Delabranche, Pierre Asfar, et al.
Annals of Intensive Care|January 24, 2020
Vasopressin and its analogues in shock states: a reviewJulien Demiselle, Nicolas Fage, Peter Radermacher, et al.
Minerva Anestesiologica|March 12, 2016
Mean arterial pressure target in patients with septic shockFrancois Beloncle, Peter Radermacher, Claude Guerin, et al.
Critical Care (London, England)|January 8, 2008
Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?Hendrik Bracht, Pierre Asfar, Peter Radermacher, et al.
Annals of Intensive Care|October 31, 2018
Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questionsOlivier Lesur, Eugénie Delile, Pierre Asfar, et al.
Current Opinion in Critical Care|December 19, 2009
The effects of vasopressin and its analogues on the liver and its disorders in the critically illPierre Asfar, Peter Radermacher, Paul Calès, et al.
Critical Care Medicine|July 17, 2014
Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*Pierre Asfar, Lakhmir Chawla, Nicolas Lerolle, et al.
Critical Care (London, England)|August 17, 2016
Does hyperoxia enhance susceptibility to secondary pulmonary infection in the ICU?Benedikt Nußbaum, Peter Radermacher, Pierre Asfar, et al.
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
American Journal of Respiratory and Critical Care Medicine|June 28, 2019
Early Use of Norepinephrine for Sepsis: Promising Results That Require ConfirmationNathan El Bèze, Antoine Kimmoun, Pierre Asfar
Intensive Care Medicine|February 17, 2026
Vasopressor use in septic shock: separating evidence, practice, and future directionsNicolas Fage, Michelle S Chew, Pierre Asfar
Critical Care (London, England)|November 12, 2010
Bench-to-bedside review: circulating microparticles--a new player in sepsis?Ferhat Meziani, Xavier Delabranche, Pierre Asfar, et al.
Annals of Intensive Care|January 24, 2020
Vasopressin and its analogues in shock states: a reviewJulien Demiselle, Nicolas Fage, Peter Radermacher, et al.
Minerva Anestesiologica|March 12, 2016
Mean arterial pressure target in patients with septic shockFrancois Beloncle, Peter Radermacher, Claude Guerin, et al.
Critical Care (London, England)|January 8, 2008
Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?Hendrik Bracht, Pierre Asfar, Peter Radermacher, et al.
Annals of Intensive Care|October 31, 2018
Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questionsOlivier Lesur, Eugénie Delile, Pierre Asfar, et al.
Current Opinion in Critical Care|December 19, 2009
The effects of vasopressin and its analogues on the liver and its disorders in the critically illPierre Asfar, Peter Radermacher, Paul Calès, et al.
Critical Care Medicine|July 17, 2014
Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*Pierre Asfar, Lakhmir Chawla, Nicolas Lerolle, et al.
Critical Care (London, England)|August 17, 2016
Does hyperoxia enhance susceptibility to secondary pulmonary infection in the ICU?Benedikt Nußbaum, Peter Radermacher, Pierre Asfar, et al.
Pageof 20